The agency flagged several violations at a compounding pharmacy owned by Hims & Hers, including “infestation by rodents, ...
Abbott (NYSE:ABT) is facing an FDA warning letter alleging quality system regulation violations related to FreeStyle Libre ...
The US Food and Drug Administration (FDA) has hit Philips with a warning letter after quality control shortcomings were uncovered at three of its medical device manufacturing sites. Issued on 9 ...
Hosted on MSN
FDA Recalls More Than 67,000 Power Stick Deodorants Due to Flaws in the Manufacturing Process
The A.P. company Deauville, responsible for the manufacturing of Power Stick deodorants, has decided to recall a total of 67,214 boxes from the market. This decision was made after identifying ...
The US Food and Drug Administration (US FDA) has completed a current good manufacturing practice (CGMP) inspection at ...
Ongoing issues at Sun Pharma’s production facility in Gujarat, India, have resulted in the FDA putting the facility on import alert status. The company announced the move by the U.S. regulatory agency ...
U.S. Food and Drug Administration has issued a warning letter to Cohance Lifesciences’ (formerly Suven Pharmaceuticals) finished dosage formulations manufacturing facility (FDF Unit-I) in Hyderabad.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results